Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
687
datasets available to search
ShareScore release 0.9.0
Dataset results
687 results for “MDS”
Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01842646. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PR1 Vaccination in Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00893997. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vosaroxin for Intermediate 2 or High-risk MDS After Failure With Hypomethylating Agent-based Therapy
ClinicalTrials.gov study NCT01980056. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions
ClinicalTrials.gov study NCT06499285. IPD Sharing: YES. Countries: 25. Publications: 0.
Fludarabine-IV Busulfan ± Clofarabine and Allogeneic Hematopoietic Stem Cell Transplantation for Acute Myeloid Leukemia (AML) and Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01471444. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Validation of a Predictive Model of Response to Romiplostim in Patients With IPSS Low or Intermediate-1 Risk MDS and Thrombocytopenia
ClinicalTrials.gov study NCT02335268. IPD Sharing: Not stated. Countries: 2. Publications: 0.
CD8 Depleted, Non-engrafting, HLA Mismatched Unrelated Infusion With MDS and Secondary AML
ClinicalTrials.gov study NCT04620681. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Myelodysplastic Syndrome (MDS) Gastrointestinal (GI) Tolerability Study
ClinicalTrials.gov study NCT01326845. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Azacitidine + Lenalidomide Combo in the Elderly With Previously Treated AML & High-Risk MDS
ClinicalTrials.gov study NCT01442714. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT04419649. IPD Sharing: YES. Countries: 8. Publications: 0.
Phase II Study of Azacitidine and Sargramostim as Maintenance Treatment for Poor-Risk AML or MDS
ClinicalTrials.gov study NCT01700673. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of Haplo-HSCT + Rivogenlecleucel vs Haplo-HSCT + Post Transplant Cyclophosphamide in Patients With AML or MDS
ClinicalTrials.gov study NCT03699475. IPD Sharing: NO. Countries: 1. Publications: 0.
Decitabine Followed by Idarubicin and Cytarabine in Treating Patients With Relapsed or Refractory AML and MDS
ClinicalTrials.gov study NCT01607645. IPD Sharing: YES. Countries: 1. Publications: 0.
Clofarabine Plus Low-Dose Cytarabine for Patients With Higher-Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01444742. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of Etavopivat for the Treatment of Anemia in Patients With Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT05568225. IPD Sharing: Not stated. Countries: 4. Publications: 0.
A Study of Epoetin Beta Treatment in Anemic Participants With Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT02145026. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Idarubicin + Cytarabine and Lenalidomide in Patients With Myelodysplastic Syndrome (MDS), Acute Myeloid Leukemia (AML)
ClinicalTrials.gov study NCT00831766. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bendamustine and Idarubicin in Treating Older Patients With Previously Untreated AML or MDS
ClinicalTrials.gov study NCT01141725. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Decitabine (DAC) w/ or w/o Valproic Acid (VPA) in Myelodysplastic Syndrome (MDS) and Acute Myelogenous Leukemia (AML)
ClinicalTrials.gov study NCT00414310. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Adoptive Transfer of Haplo-identical DLI for AML and MDS
ClinicalTrials.gov study NCT02046122. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.